{
  "meta": {
    "title": "Phenylalanine_Tyrosine_Metabolism",
    "url": "https://brainandscalpel.vercel.app/phenylalanine-tyrosine-metabolism-271ebe28.html",
    "scrapedAt": "2025-11-29T18:23:02.254Z"
  },
  "questions": [
    {
      "id": 7422,
      "choices": [
        {
          "id": 29656,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to deficiency of enzyme Phenylalanine Hydroxylase</span></p>"
        },
        {
          "id": 29657,
          "text": "<p><span style=\"font-size:12.0pt;\">Mental retardation is a potential complication</span></p>"
        },
        {
          "id": 29658,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of a white patch of hair is due to a deficiency in tryptophan</span></p>"
        },
        {
          "id": 29659,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylacetate is found in the urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a routine neonatal examination, a newborn girl is noted to have blue eyes, blond hair, and fair skin. A Guthrie test is performed, yielding positive results. Among the following statements related to this case, which one is NOT true?</span></p>",
      "unique_key": "Q6984223",
      "question_audio": null,
      "question_video": null,
      "map_id": 30619,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Presence of a white patch of hair is due to a deficiency in tryptophan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This case describes a newborn with classic physical features of phenylketonuria (PKU) - blue eyes, blond hair, and fair skin - who has tested positive on the Guthrie test, a screening test for elevated phenylalanine levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Statement C is incorrect because the hypopigmentation (lighter hair and skin) seen in PKU is not related to tryptophan deficiency. Rather, it results from Reduced tyrosine availability (since phenylalanine cannot be converted to tyrosine)</span></p><p><span style=\"font-size:12.0pt;\">Tryptophan is an essential amino acid involved in serotonin synthesis, but it does not play a direct role in the pigmentation pathways affected in PKU.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Due to deficiency of enzyme Phenylalanine Hydroxylase</strong>: This statement is true. PKU is caused by mutations in the gene encoding phenylalanine hydroxylase (PAH), which normally converts phenylalanine to tyrosine. Without functional PAH, phenylalanine accumulates to toxic levels in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mental retardation is a potential complication</strong>: This statement is true. Untreated PKU can lead to significant intellectual disability due to the neurotoxic effects of elevated phenylalanine and its metabolites. Early diagnosis and dietary management can prevent this outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenylacetate is found in the urine</strong>: This statement is true. In PKU, the excess phenylalanine is metabolized through alternative pathways, producing phenylketones including phenylpyruvate, phenyllactate, and phenylacetate, which are excreted in the urine. The presence of these compounds gives PKU its name and produces the characteristic \"musty\" or \"mousy\" odor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phenylketonuria results from phenylalanine hydroxylase deficiency, causing elevated phenylalanine levels and reduced tyrosine. The hypopigmentation seen in PKU patients is due to impaired melanin synthesis from reduced tyrosine availabilityâ€”not from tryptophan deficiency. Early detection through newborn screening and prompt dietary management are essential to prevent the neurological sequelae of this inborn error of metabolism.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 304-306</span></p>",
      "correct_choice_id": 29658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7436,
      "choices": [
        {
          "id": 29712,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylalanine</span></span></span></span></p>"
        },
        {
          "id": 29713,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptophan</span></span></span></span></p>"
        },
        {
          "id": 29714,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine</span></span></span></span></p>"
        },
        {
          "id": 29715,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histidine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male presents with intermittent involuntary tremors in his left hand, difficulty feeding himself, walking challenges, and poor gait coordination for the past month. Upon examination, he exhibits a shuffling gait and resting tremors, but cognitive functions remain intact. Diagnosed with Parkinson&#39;s disease, he is prescribed levodopa. Which metabolic pathway is primarily affected in this condition?</span></span></span></span></p>",
      "unique_key": "Q1338116",
      "question_audio": null,
      "question_video": null,
      "map_id": 30613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyrosine</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture8_lTZg06l.jpg\" style=\"height:216px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinson disease is due to defective dopamine synthesis in the substania nigra &rarr;dopamine content in brain is reduced.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine is derived from tyrosine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment with L-DOPA in the initial stages of the disease provides relief from the symptoms. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Phenylalanine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While phenylalanine is a <strong>precursor to tyrosine</strong>, the direct pathway affected in Parkinson&#39;s disease is the tyrosine to dopamine pathway.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Tryptophan:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Involved in the <strong>synthesis of serotonin and melatonin</strong>, not directly implicated in Parkinson&#39;s disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Histidine: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involved in the <strong>synthesis of histamine</strong> and is not directly related to the dopaminergic pathways affected in Parkinson&#39;s disease.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parkinson&#39;s disease</strong> is associated with the <strong>dopaminergic pathway</strong>, where <strong>tyrosine</strong> is a <strong>key precursor</strong> in the <strong>synthesis of dopamine.</strong> <strong>Levodopa</strong>, a <strong>precursor of dopamine</strong>, is used to <strong>increase dopamine levels</strong> in the <strong>brain,</strong> addressing the dopamine deficiency that characterizes <strong>Parkinson&#39;s disease.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 235.</span></span></strong></span></span></p>",
      "correct_choice_id": 29714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7438,
      "choices": [
        {
          "id": 29720,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type-2</span></span></span></span></p>"
        },
        {
          "id": 29721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type-1</span></span></span></span></p>"
        },
        {
          "id": 29722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type-3</span></span></span></span></p>"
        },
        {
          "id": 29723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hawkinsinuria</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old male child presents with a 5-month history of eye ulceration and thick, rough, patchy skin on the palms and feet. Examination reveals dendritic corneal ulceration unresponsive to antiviral treatment and keratosis on the palms and plantar surfaces. Laboratory tests show increased levels of tyrosine in blood and urine. What is the most likely diagnosis?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture9.jpg\" style=\"height:249px; width:300px\" /></p>",
      "unique_key": "Q6482603",
      "question_audio": null,
      "question_video": null,
      "map_id": 30614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyrosinemia type 2</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinemia type-2/Oculocutaneous Tyrosinemia/Richner-Hanhart Syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is due to <strong>deficiency of Tyrosine Transaminase.</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F- Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>diet low in protein</strong> is advised.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is due to a <strong>deficiency of enzyme fumarylacetoacetate hydrolase</strong>. C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neonatal Tyrosinemia (Tyrosinemia Type III)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> due to the <strong>absence </strong>of the <strong>enzyme para-hydroxyphenylpyruvate hydroxylase</strong>, which causes <strong>transient hypertyrosinemia</strong> in the <strong>newborn</strong>, and this will respond to ascorbic acid and dietary protein restriction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hawkinsinuria</strong> is due to <strong>dysfunction of p-HPPA oxidase,</strong> characterized by <strong>excretion of hawkinsin in urine</strong>, a derivative of p-HPPA.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosinemia type-2,</strong> also known as <strong>Richner-Hanhart syndrome,</strong> is characterized by <strong>elevated levels of tyrosine </strong>which can <strong>lead to eye problems</strong> (like corneal ulcers), <strong>skin disorders</strong> (such as palmoplantar keratosis), and sometimes <strong>intellectual disability.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 239.</span></span></strong></span></span></p>",
      "correct_choice_id": 29720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7431,
      "choices": [
        {
          "id": 29692,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased tyrosinase activity will be observed in melanocytes</span></span></span></span></p>"
        },
        {
          "id": 29693,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It results in photophobia</span></span></span></span></p>"
        },
        {
          "id": 29694,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mental retardation is the main characteristic feature in albinism</span></span></span></span></p>"
        },
        {
          "id": 29695,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin has high pigmentation in albinism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant with pale skin and blonde hair is presented to the pediatric outpatient department by her parents. The infant has two siblings with complete albinism, while both parents are phenotypically normal. Based on this family history and the clinical presentation, which statement is correct regarding albinism?</span></span></span></span></p>",
      "unique_key": "Q3945596",
      "question_audio": null,
      "question_video": null,
      "map_id": 30610,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It results in photophobia </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albinism is an AR disease with <strong>completely absence of tyrosinase</strong> &rarr;defective synthesis of melanin. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ocular fundus is hypopigmented and the iris would be gray or red with photophobia, nystagmus and decreased visual acuity. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The skin has <strong>low pigmentation</strong>, is sensitive to UV-rays with presence of nevi and melanomas. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hair of the patient is also white. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NO Mental retardation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increased tyrosinase activity:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect. Albinism is usually associated with decreased or absent activity of tyrosinase in melanocytes, not increased activity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>C. Mental retardation:</strong> Incorrect. Albinism does not inherently affect cognitive function; mental retardation is not a characteristic feature of albinism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>D. Skin has high pigmentation:</strong> Incorrect. Albinism is defined by reduced or absent pigmentation in the skin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albinism is characterized by a deficiency or absence of melanin pigmentation and can often result in photophobia due to the lack of melanin in the iris and retinal pigment epithelium. This causes increased light penetration into the eye, leading to discomfort in bright environments.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/ed: p 238.</span></span></strong></span></span></p>",
      "correct_choice_id": 29693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7429,
      "choices": [
        {
          "id": 29684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Father is a carrier of PKU&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 29685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal translocation with unbalanced segregation in meiosis I</span></span></span></span></p>"
        },
        {
          "id": 29686,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal translocation with unbalanced segregation in meiosis II&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 29687,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylalanine was not adequately restricted from the mother&rsquo;s diet during pregnancy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman of reproductive age with phenylketonuria (PKU) delivers her first child. The father has no family history of PKU. At birth, the neonate presents with microcephaly and elevated blood phenylalanine levels. Considering the mother&#39;s medical history and the absence of PKU in the father&#39;s family, what is the most likely explanation for the neonate&#39;s symptoms?</span></span></span></span></p>",
      "unique_key": "Q9800616",
      "question_audio": null,
      "question_video": null,
      "map_id": 30609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Phenylalanine was not adequately restricted from the mother&rsquo;s diet during pregnancy</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>child is affected at birth</strong> itself due to <strong>in-utero exposure </strong>to <strong>high levels of maternally</strong> derived phenylalanine.&nbsp; </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pregnant women</strong> with <strong>PKU </strong>must strictly <strong>adhere to the special diet</strong> to <strong>avoid the adverse effects </strong>on the<strong> fetus.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Father is a carrier of PKU:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Even if the <strong>father is a carrier of PKU allele </strong>(phenylalanine hydroxylase gene), the <strong>infant will not have any symptoms </strong>until <strong>4-5 days after birth,</strong> also the maternal blood phenylalanine level should be in the normal range throughout the course of pregnancy.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Maternal translocation with unbalanced segregation in meiosis I </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Option C. Maternal translocation with unbalanced segregation in meiosis II:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Maternal translocation</strong> with <strong>unbalanced segregation in meiosis I</strong> and <strong>meiosis II </strong>will <strong>not</strong> have effect on phenylalanine levels but leads to trisomy.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Maternal PKU syndrome, </strong>occurs when a <strong>mother with PKU</strong> does <strong>not adequately control her phenylalanine levels</strong> during <strong>pregnancy.</strong> <strong>Elevated phenylalanine</strong> in the <strong>maternal bloodstream</strong> can <strong>cross the placenta</strong>, affecting <strong>fetal development</strong> and leading to conditions such as <strong>microcephaly</strong> and <strong>elevated blood phenylalanine</strong> in the <strong>newborn</strong>, despite the child not inheriting PKU.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 304,306.</span></span></strong></p>",
      "correct_choice_id": 29687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7433,
      "choices": [
        {
          "id": 29700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine Hydroxylase</span></span></span></span></p>"
        },
        {
          "id": 29701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homogentisate Oxidase</span></span></span></span></p>"
        },
        {
          "id": 29702,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine Transaminase</span></span></span></span></p>"
        },
        {
          "id": 29703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinase</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with severe back pain and difficulty in walking is observed to have a bluish-black discoloration of the ear cartilage and darkening of the urine upon standing. Which enzyme deficiency is most likely responsible for his condition? </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6_08b8XZK.jpg\" style=\"height:97px; width:300px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q2293420",
      "question_audio": null,
      "question_video": null,
      "map_id": 30611,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Homogentisate Oxidase:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Biochemical defect</strong> of <strong>Homogentisate oxidase </strong>&rarr; Alkaptonuria (AR inheritance) &rarr; results in excretion of homogentisic acid in urine.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F-</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> blackening of urine on standing (Homogentisic acid is oxidized to benzoquinone acetate &rarr; polymerized to black coloured alkapton bodies). </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ochronosis</strong> (deposition of alkapton bodies in intervertebral discs, cartilages of nose, pinna of ear) </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Black pigments </strong>are <strong>deposited over the connective tissues </strong>including <strong>joint cavities to produce arthritis</strong>.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No specific treatment, minimal protein intake with phenylalanine is advised.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tyrosine Hydroxylase: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosine</strong> is <strong>hydroxylated to dihydroxyphenylalanine</strong> (DOPA) by <strong>tyrosine hydroxylase,</strong> which <strong>requires BH4 and NADPH. </strong>Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is used for catecholamine synthesis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tyrosine Transaminase: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency<strong> </strong>leads to <strong>Oculocutaneous Tyrosinemia </strong>(Tyrosinemia Type II), <strong>C/F</strong>- Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tyrosinase:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is <strong>completely absent </strong>&rarr;<strong>defective synthesis of melanin</strong> &rarr;<strong>AR disease</strong>, <strong>Albinism</strong>. <strong>C/F</strong>- skin has low pigmentation &rarr;sensitive to UV rays &rarr;nevi and melanomas, white hair, ocular fundus is hypopigmented and iris may be gray or red, photophobia, nystagmus and decreased visual acuity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alkaptonuria</strong> is characterized by the <strong>accumulation of homogentisic acid</strong>, a <strong>metabolic byproduct of phenylalanine </strong>and <strong>tyrosine catabolism</strong>. This <strong>accumulation</strong> is due to a <strong>deficiency in the enzyme homogentisate oxidase.</strong> The hallmark features of this condition include darkening of the urine upon standing (due to the oxidation of homogentisic acid), ochronosis (bluish-black discoloration of connective tissues), and arthropathies (joint diseases), particularly affecting the spine and large joints.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 304-305.</span></span></strong></span></span></p>",
      "correct_choice_id": 29701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7446,
      "choices": [
        {
          "id": 29752,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine</span></p>"
        },
        {
          "id": 29753,
          "text": "<p><span style=\"font-size:12.0pt;\">5-hydroxytryptophan</span></p>"
        },
        {
          "id": 29754,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanin</span></p>"
        },
        {
          "id": 29755,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following routine newborn screening, a child is found to have high levels of phenylpyruvate and phenylacetate, indicative of phenylketonuria (PKU). Despite a phenylalanine-restricted diet, the child shows developmental delays. Which supplement might improve the child's condition?</span></p>",
      "unique_key": "Q7001381",
      "question_audio": null,
      "question_video": null,
      "map_id": 30615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Tyrosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phenylketonuria (PKU) results from a deficiency of phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine. This deficiency leads to:</span></p><ol><li><span style=\"font-size:12.0pt;\">Accumulation of phenylalanine and its metabolites (phenylpyruvate, phenylacetate, phenyllactate)</span></li><li><span style=\"font-size:12.0pt;\">Reduced tyrosine production, making tyrosine an essential amino acid in PKU patients</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In PKU treatment, dietary phenylalanine restriction is the primary approach to prevent neurotoxicity from excess phenylalanine. However, this restriction alone can lead to tyrosine deficiency, as tyrosine can no longer be synthesized from phenylalanine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tyrosine is critical for:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Production of neurotransmitters (dopamine, norepinephrine, epinephrine)</span></li><li><span style=\"font-size:12.0pt;\">Synthesis of thyroid hormones</span></li><li><span style=\"font-size:12.0pt;\">Melanin production</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tyrosine supplementation is therefore beneficial in PKU management as it:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Addresses the conditionally essential status of tyrosine</span></li><li><span style=\"font-size:12.0pt;\">Supports neurotransmitter synthesis, potentially improving neurological function</span></li><li><span style=\"font-size:12.0pt;\">May reduce the risk of developmental delays associated with tyrosine deficiency</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 5-hydroxytryptophan</strong>: This is a precursor to serotonin in the tryptophan metabolism pathway. While serotonin levels might be indirectly affected in PKU due to competition between elevated phenylalanine and tryptophan for transport across the blood-brain barrier, supplementing with 5-hydroxytryptophan does not address the primary biochemical defect or the tyrosine deficiency in PKU.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Melanin</strong>: This is an end product of tyrosine metabolism and not a supplement that would provide therapeutic benefit in PKU. The hypopigmentation sometimes seen in PKU patients is due to reduced tyrosine availability for melanin synthesis, but direct melanin supplementation would not address the metabolic or neurological issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenylalanine</strong>: Supplementing with phenylalanine would be contraindicated in PKU as it would exacerbate the condition. PKU patients already have elevated phenylalanine levels due to impaired metabolism, and additional phenylalanine would increase toxic metabolite production and neurological damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In phenylketonuria, phenylalanine hydroxylase deficiency creates a metabolic block in converting phenylalanine to tyrosine. While dietary phenylalanine restriction is the mainstay of treatment, supplementation with tyrosine is important because it becomes an essential amino acid in this condition. Tyrosine supplementation supports neurotransmitter synthesis, and potentially improves developmental outcomes by addressing the \"downstream\" deficiency caused by the enzymatic block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 236.</span></p>",
      "correct_choice_id": 29752,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7450,
      "choices": [
        {
          "id": 29768,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acidosis due to elevated phenyllactate</span></span></span></span></p>"
        },
        {
          "id": 29769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of tyrosine, now an essential amino acid</span></span></span></span></p>"
        },
        {
          "id": 29770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of hydroxylating enzymes due to accumulation of phenylalanine</span></span></span></span></p>"
        },
        {
          "id": 29771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of large, neutral amino acids in the brain.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child with developmental delay undergoes blood analysis, which reveals elevated levels of phenylalanine, phenyllactate, and phenylpyruvate. What is the hypothesized mechanism for developmental delay in this condition?</span></span></span></span></p>",
      "unique_key": "Q2811701",
      "question_audio": null,
      "question_video": null,
      "map_id": 30617,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lack of large, neutral amino acids in the brain</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>child has PKU</strong>, the <strong>elevated phenylalanine levels </strong>in the <strong>blood are saturating the large</strong>, <strong>neutral amino acid transport protein </strong>in the <strong>nervous system</strong>, thus <strong>preventing </strong>other <strong>substrates from entering the brain </strong>(such as tryptophan, tyrosine, lysine and leucine). </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>alters the ability </strong>of the <strong>brain to synthesize proteins </strong>&rarr;causing <strong>neurological problems</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Providing large amounts of these large, neutral amino acids</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> prevents <strong>saturation of the system </strong>by <strong>phenylalanine </strong>and can be used as a <strong>treatment </strong>along with <strong>restricted phenylalanine diet </strong>for <strong>children with this disorder</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A. Acidosis due to elevated phenyllactate:</strong> While <strong>acidosis </strong>can have <strong>deleterious effects </strong>on the <strong>body </strong>and can be a <strong>feature of organic acidemias</strong>, it is not the primary reason for developmental delays in conditions like phenylketonuria. Acidosis is more of an acute metabolic disturbance rather than a direct cause of chronic developmental issues.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B. Lack of tyrosine, now an essential amino acid: Tyrosine </strong>is a <strong>precursor for several neurotransmitters</strong>, and while its <strong>deficiency </strong>due to a <strong>block in conversion from phenylalanine </strong>can <strong>impact brain function</strong>, the developmental delay is more directly linked to the broader competition of phenylalanine with other LNAAs, rather than tyrosine deficiency alone.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>C. Inhibition of hydroxylating enzymes due to accumulation of phenylalanine:</strong> <strong>Phenylalanine </strong>can indeed <strong>inhibit certain enzymes</strong>, including <strong>hydroxylating enzymes</strong>, due to its <strong>elevated levels</strong>. This can have various metabolic effects, but the specific link to developmental delay is less direct compared to the competition of phenylalanine with other LNAAs for transport into the brain.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevated levels </strong>of <strong>phenylalanine </strong>are known to <strong>interfere with the transport of other large</strong>, <strong>neutral amino acids </strong>(LNAAs) across the <strong>blood-brain barrier </strong>due to <strong>competitive inhibition</strong>. These LNAAs include tyrosine, tryptophan, and others that are precursors for key neurotransmitters essential for brain development and function. A deficiency in these neurotransmitters can result in developmental delays.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp; DM Vasudevan 9/e: p 236.</span></span></strong></span></span></p>",
      "correct_choice_id": 29771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7453,
      "choices": [
        {
          "id": 29780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alanine</span></span></span></span></p>"
        },
        {
          "id": 29781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tryptophan</span></span></span></span></p>"
        },
        {
          "id": 29782,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine</span></span></span></span></p>"
        },
        {
          "id": 29783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histidine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old boy presents to the outpatient department with failure to thrive, poor appetite, hepatomegaly, yellow discoloration of the eyes, vomiting, diarrhea, and a distinct cabbage-like odor. What amino acid metabolism defect is this disorder most likely associated with?</span></span></span></span></p>",
      "unique_key": "Q3348437",
      "question_audio": null,
      "question_video": null,
      "map_id": 30618,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyrosine</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The boy has <strong>tyrosinemia type I</strong>, which is due to the defect in <strong>fumarylacetoacetate hydrolase</strong>, the last step in the degradation pathway for tyrosine. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In its <strong>acute form</strong>, this disorder will lead to <strong>liver failure</strong> and <strong>death within 1 year of life</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>accumulation of intermediates</strong> in the <strong>tyrosine degradation pathway</strong> triggers <strong>apoptosis of the hepatocytes</strong> &rarr;causing <strong>complete liver failure </strong>that presents as <strong>yellowish discoloration of eyes</strong> due to accumulated bilirubin. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A. Alanine: </strong>While alanine is an <strong>amino acid,</strong> it is not commonly associated with the symptoms described or a distinct odor.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B. Tryptophan:</strong> <strong>Abnormal tryptophan metabolism</strong> can lead to <strong>several conditions,</strong> but the distinct clinical picture including odor does not typically link to tryptophan metabolism defects.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>D. Histidine: Disturbances</strong> in <strong>histidine metabolism</strong>, such as <strong>histidinemia</strong>, do not typically present with the constellation of symptoms described in the question.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of<strong> tyrosinemia type I</strong>, includes <strong>failure to thrive, poor appetite, hepatomegaly, jaundice, vomiting, diarrhea,</strong> and a <strong>distinct odor</strong> resembling <strong>cabbage</strong> due to the <strong>accumulation of tyrosine metabolites.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp; DM Vasudevan 9/e: p 239.</span></span></strong></span></span></p>",
      "correct_choice_id": 29782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7457,
      "choices": [
        {
          "id": 29796,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine</span></span></p>"
        },
        {
          "id": 29797,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyramine</span></span></p>"
        },
        {
          "id": 29798,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></span></p>"
        },
        {
          "id": 29799,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient on antidepressants experienced an increased heart rate and sweating after consuming red wine and aged cheese. These symptoms are due to an inability to degrade which substance?</span></span></span></span></p>",
      "unique_key": "Q1784997",
      "question_audio": null,
      "question_video": null,
      "map_id": 30608,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyramine</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyramine</strong> is a <strong>degradation product of tyrosine</strong> (decarboxylated tyrosine) which when <strong>elevated leads to norepinephrine release. </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sources of Tyramine</strong>: <strong>red wine</strong> and <strong>aged food items</strong> such as cheeses. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>ingested, tyramine is degraded</strong> by <strong>monoamine oxidase</strong> to <strong>form a harmless compound</strong> and excessive norepinephrine release does not occur. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">But, if a patient is taking a <strong>monoamine oxidase inhibitor</strong> (MAOI), it is possible that <strong>tyramine does not get degraded appropriately</strong> ðŸ¡ª a high tyramine level causes highly elevated blood pressure due to the release of norepinephrine. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MAOIs </strong>which <strong>covalently modify the enzyme </strong>are very <strong>useful medications</strong> for <strong>atypical depression </strong>which is unresponsive to other modalities and these MAOIs have many interactions with many other medications and foods. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence Patients on MAOIs need to avoid foods high in tyramine such as cheeses (aged and processed) red wine, caviar, brewer&rsquo;s yeast, miso soup, dried herring and aged meats and they have <strong>no effect on glycoproteins or cholesterol</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Tyrosine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyrosine is a <strong>precursor to tyramine </strong>and <strong>various neurotransmitters</strong> but is not directly responsible for the described symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Serotonin: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While serotonin syndrome can <strong>result from certain drug interactions,</strong> particularly with <strong>serotonergic agents</strong>, the specific trigger of aged cheese and red wine points more towards a tyramine interaction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Glycine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glycine is an <strong>inhibitory neurotransmitter </strong>in the <strong>central nervous system</strong> and is not related to the symptoms described in the context of dietary intake and antidepressants.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>hypertensive crisis</strong> can occur from <strong>consuming tyramine-rich foods</strong> while on <strong>MAOIs,</strong> as these <strong>antidepressants inhibit</strong> the <strong>breakdown of tyramine</strong>, leading to symptoms like <strong>increased heart rate and sweating.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp; DM Vasudevan 9/e: p 236, 555.</span></span></strong></span></span></p>",
      "correct_choice_id": 29797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7425,
      "choices": [
        {
          "id": 29668,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperornithinemia&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 29669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperuricemia&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 29670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 29671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypervalinemia&nbsp; </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old girl has been diagnosed with an inherited metabolic disorder. Her mother is cautioned that consuming &quot;sugar-free&quot; products containing aspartame could be harmful to her daughter&#39;s health. Based on this advice, which genetic disorder is the girl most likely to have?</span></span></span></span></p>",
      "unique_key": "Q7458788",
      "question_audio": null,
      "question_video": null,
      "map_id": 30607,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Phenylketonuria </strong>&nbsp;&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">People with hyperphenylalaninemia shouldn&#39;t be administered with any product which contains phenylalanine such as aspartame, as it is detrimental to his or her general health.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The hyperphenylalaninemia are the result of impaired conversion of phenylalanine to tyrosine.&nbsp; </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most clinically important among this condition is phenylketonuria which is due to deficiency of enzyme phenylalanine hydroxylase results in increased concentration of phenylalanine in blood, increased concentration of phenylalanine and its by-products (such as phenylpyruvate, phenylalanine and phenylacetate) in urine and mental retardation.&nbsp; </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hyperornithinemia:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition involves elevated levels of ornithine and is not directly related to aspartame consumption. Treatment- Low protein diet.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hyperuricemia:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by elevated uric acid levels, it is not influenced by aspartame intake in the context described. Treatment- Reduce dietary intake of purine and restrict alcohol, uricosuric drugs (decrease the reabsorption of uric acid from kidney tubules) and reduce the urate production by allopurinol (analog of hypoxanthine).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypervalinemia: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involving elevated levels of valine, this condition is also not impacted by the consumption of aspartame. Treatment<strong> -</strong>Restrict valine in diet.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria (PKU) is an inherited metabolic disorder characterized by a deficiency in the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p304-306</span></span></strong></p>",
      "correct_choice_id": 29670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7449,
      "choices": [
        {
          "id": 29764,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 29765,
          "text": "<p><span style=\"font-size:12.0pt;\">NADPH oxidase</span></p>"
        },
        {
          "id": 29766,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosinase</span></p>"
        },
        {
          "id": 29767,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisic acid oxidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newborn present with milky white skin, white hair, and red-appearing eyes. Which enzyme defect is most commonly associated with this disorder?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12_CnQINfC.jpg\" alt=\"\" width=\"300\" height=\"280\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\">&nbsp;</p>",
      "unique_key": "Q8064785",
      "question_audio": null,
      "question_video": null,
      "map_id": 30616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Tyrosinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The clinical presentation described (milky white skin, white hair, and red-appearing eyes) is characteristic of oculocutaneous albinism (OCA). This condition results from a deficiency of tyrosinase, a copper-containing enzyme that catalyzes the steps in melanin biosynthesis:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tyrosinase is critical for melanin production in melanocytes. Without functional tyrosinase, melanin synthesis is impaired or absent, resulting in hypopigmentation of the skin, hair, and eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The red-appearing eyes are due to the absence of melanin in the iris, allowing the blood vessels of the retina to be visible.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img class=\"image_resized\" style=\"aspect-ratio:350/207;width:79.31%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14_scyWKAh.jpg\" alt=\"\" width=\"350\" height=\"207\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenylalanine hydroxylase</strong>: Deficiency of this enzyme leads to phenylketonuria, which is characterized by an inability to metabolize phenylalanine, leading to intellectual disability and other problems, not albinism.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NADPH oxidase</strong>: Defects in this enzyme are associated with chronic granulomatous disease, which affects the immune system, not pigmentation.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Homogentisic acid oxidase</strong>: A defect in this enzyme results in alkaptonuria, which leads to the buildup of homogentisic acid causing dark urine and possibly ochronosis, but not albinism.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Albinism is most often caused by a defect in the enzyme tyrosinase, leading to a lack of melanin production and the associated clinical presentation of white skin, white hair, and red-appearing eyes.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 234,238.</span></p>",
      "correct_choice_id": 29766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7435,
      "choices": [
        {
          "id": 29708,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine Hydroxylase</span></span></span></span></p>"
        },
        {
          "id": 29709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homogentisate Oxidase</span></span></span></span></p>"
        },
        {
          "id": 29710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine Transaminase</span></span></span></span></p>"
        },
        {
          "id": 29711,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosinase</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old male visits a dermatology clinic in India with white patches on the dorsal aspect of his left hand, progressively worsening over the past 3 months. Which enzyme is essential for melanin synthesis, possibly deficient in this patient?</span></span></span></span></p>",
      "unique_key": "Q2626021",
      "question_audio": null,
      "question_video": null,
      "map_id": 30612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D.</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tyrosinase</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucoderma/vitiligo: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When tyrosinase or melanin forming cells or<strong> </strong>both are absent from epidermis, leukoderma (white patches) results.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7_pW8DEa3.jpg\" style=\"height:207px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tyrosine Hydroxylase: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase, which requires BH4 and NADPH. Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is <strong>used for catecholamine synthesis.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B Homogentisate Oxidase </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&rarr;Alkaptonuria (AR inheritance) &rarr;results in excretion of homogentisic acid in urine.<strong> C/F-</strong> blackening of urine on standing, Ochronosis and Black pigments over joint cavities to produce arthritis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tyrosine Transaminase: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency<strong> </strong>leads to Oculocutaneous Tyrosinemia (Tyrosinemia Type II), <strong>C/F</strong>- Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Melanin synthesis requires the enzyme tyrosinase, which catalyzes the oxidation of tyrosine to DOPA and DOPAquinone, key steps in the production of melanin. A deficiency or functional impairment in tyrosinase can lead to conditions like vitiligo or albinism, characterized by the loss of pigmentation in the skin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 239.</span></span></strong></span></span></p>",
      "correct_choice_id": 29711,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}